The Group

We conduct research that applies pharmacoepidemiologic methods to advance the assessment of medication safety and effectiveness in chronic disease management. Of primary clinical interest is the role of metabolic syndrome, including obesity, on the safety and effectiveness of medications in musculoskeletal and rheumatic diseases. This includes an improved understanding of the multimorbidity within these patients and developing methods to improve prediction of treatment success by means of traditional statistics as well as machine learning techniques. As a result, our group is also keenly interested developing new methods to advance the precision of estimates. This includes developing strategies to better understand and overcome the impact of missing data and variables in our data sources, but also ways to better combine traditional healthcare and biobank data.

We also focus on the development of sound methodological skills through regular journal club meetings and developing critical appraisal skills when reading scientific literature. This promotes critical and independent thinking, which is essential for individuals in all aspects of health care – academia, industry and health care professionals (pharmacists and physicians).

JavaScript has been disabled in your browser